{
    "clinical_study": {
        "@rank": "58828", 
        "arm_group": [
            {
                "arm_group_label": "Dexamethasone", 
                "arm_group_type": "Experimental", 
                "description": "Dexamethasone"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Sterile normal saline solution"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators hypothesize that preoperative administration of 8 mg IV dexamethasone will\n      benefit patients' perceived quality of recovery after surgery."
        }, 
        "brief_title": "Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pelvic Organ Prolapse", 
            "PONV"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Prolapse", 
                "Pelvic Organ Prolapse"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a randomized controlled trial involving single administration of 8 mg Dexamethasone\n      per IV preoperatively among women undergoing vaginal reconstructive surgery for pelvic organ\n      prolapse."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women aged 18-81 years old who are scheduled to undergo a major vaginal\n             reconstructive surgery, including hysterectomy  with or without hysterectomy\n\n        Exclusion Criteria:\n\n          -  Daily use of steroids or antiemetic agents such as Zofran, Reglan, Compazine and\n             Phenargan within one month of surgery\n\n          -  Regional anesthesia for surgical procedure\n\n          -  Chronic pain requiring opioid treatment daily\n\n          -  History of allergy to the study medication\n\n          -  Severe renal and liver disease\n\n          -  Pregnancy\n\n          -  Non English speaking\n\n          -  Psychiatric disorder that will preclude completion of questionnaires\n\n          -  Minor surgery that does not involve overnight admission\n\n          -  Surgery that does not involve hysterectomy or vaginal intraperitoneal apical\n             suspension\n\n          -  Hypersensitivity reaction to steroids\n\n          -  Evidence of systemic fungal infection\n\n          -  Evidence of any systemic infection\n\n          -  Uncontrolled diabetes"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "81 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "62", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02073734", 
            "org_study_id": "12136-12-081"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dexamethasone", 
                "description": "Dexamethasone 8mg/IV", 
                "intervention_name": "Dexamethasone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Dexamethasone acetate", 
                "Dexamethasone", 
                "Dexamethasone 21-phosphate", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pelvic organ prolapse surgery", 
            "dexamethasone", 
            "postoperative nausea and vomiting", 
            "peroperative administration"
        ], 
        "lastchanged_date": "April 4, 2014", 
        "location": {
            "contact": {
                "email": "Vivian_Ghodsi@trihealth.com", 
                "last_name": "Vivian Ghodsi, RN CCRC", 
                "phone": "513-853-4213"
            }, 
            "contact_backup": {
                "email": "Angie_Fellner@trihealth.com", 
                "last_name": "Angela N Fellner, PhD", 
                "phone": "513-862-2330"
            }, 
            "facility": {
                "address": {
                    "city": "Cincinnati", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "45220"
                }, 
                "name": "Triheath"
            }, 
            "investigator": [
                {
                    "last_name": "Maria Victoria Estanol, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Susan Oakley, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Catrina Crisp, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Lauren Westermann, DO", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Steven Kleeman, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Rachel Pauls, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Donna Mazloomdoost, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of Preoperative Dexamethasone on Postoperative Quality of Recovery Following Vaginal Reconstructive Surgery: A Randomized Controlled Trial", 
        "overall_contact": {
            "email": "Vivian_Ghodsi@trihealth.com", 
            "last_name": "Vivian Ghodsi, RN CCRC", 
            "phone": "513-853-4213"
        }, 
        "overall_contact_backup": {
            "email": "Angie_Fellner@trihealth.com", 
            "last_name": "Angela N Fellner, PhD", 
            "phone": "513-862-2330"
        }, 
        "overall_official": [
            {
                "affiliation": "TriHealth Good Samaritan Hospital", 
                "last_name": "Rachel N Pauls, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "TriHeath Good Samaritan Hospital", 
                "last_name": "Rachel N Pauls, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The QoR-40 is a validated standardized questionnaire that assesses the dimensions of physical functioning, mental health, cognitive functioning, symptoms, role and social functioning, general health perceptions, sleep and energy", 
            "measure": "The primary endpoint will be scores on the 40- item quality of recovery scoring system (QoR-40).", 
            "safety_issue": "Yes", 
            "time_frame": "up to 20-24 hours after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02073734"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "To determine if dexamethasone has positive impact on other clinical recovery variables such as nausea, vomiting and pain.", 
            "safety_issue": "No", 
            "time_frame": "20-24 hours after surgery"
        }, 
        "source": "TriHealth Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "TriHealth Inc.", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}